Clinical Trial Update: Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial assessing pazopanib, lapatinib, or trastuzumab in subjects with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Tykerb (lapatinib)
• Votrient (Pazopanib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 1 | Status: COMPLETED